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Pathogens that reside in the phagosomes of infected
cells persist despite the presence of potent T cell
responses.We addressed themechanismof immune
evasion by using amousemodel of Salmonella typhi-
murium (ST). Recombinants of ST were generated
that translocated antigen to the cytosol or phago-
somes of infected cells. We find that the kinetics of
antigenpresentation andCD8+Tcell priming is accel-
erated by cytosolic antigen delivery, although the
magnitude of CD8+ T cell response is not influenced
by antigenic location. More importantly, only those
targets that readily displayantigenon thecell surface,
owing to antigenic translocation to the cytosol, are
recognized and killed by CD8+ T cells. Thus, vaccina-
tion approaches developed to control phagosomal
pathogens should incorporate methods for modu-
lating antigen presentation such that infected target
cells can be readily recognized by CD8+ T cells.INTRODUCTION
After antigen presentation, naive CD8+ T cells undergo differen-
tiation into effectors that eliminate infected cells (Prlic et al.,
2007). CD8+ T cells are activated rapidly during infection with
intracellular pathogens such as lymphocytic choriomeningitis
virus (LCMV) or Listeria monocytogenes (LM), which facilitates
pathogen control (van Stipdonk et al., 2001; Kaech and Ahmed,
2001). However, in cases of pathogens that reside in phago-
somes, such as Salmonella serovar typhimurium (ST) and myco-
bacteria, activation of CD8+ T cells is delayed (Luu et al., 2006;
van Faassen et al., 2004; Vidric et al., 2006; Srinivasan et al.,
2004b), suggesting a correlation to chronic infection. Activation
of CD8+ T cells by alternative routes of cross-presentation
have been reported in the case of phagosomal pathogens (Scha-
ible et al., 2003; Houde et al., 2003; Yrlid and Wick, 2000).
ST survives within the phagosomes of host cells, and its intra-
cellular replication is essential for virulence (Leung and Finlay,1710 Cell Reports 2, 1710–1721, December 27, 2012 ª2012 The Aut1991). ST induces a systemic typhoid-like disease in mice and
gastroenteritis in humans (Jones and Falkow, 1996). Suscepti-
bility to ST has been associated with a mutation in the natural
resistance-associated macrophage protein (NRAMP) gene in
macrophages (Bellamy, 1999). 129X1SvJ or B6.129F1 mice
(which have a normal NRAMP gene) are resistant to infection,
but ST is not completely eliminated and a chronic infection
ensues (Luu et al., 2006). The mechanisms behind the persis-
tence of ST despite induction of potent T cell response are not
clear (Srinivasan et al., 2004b; Luu et al., 2006).
CD4+ T cells recognize antigens on the major histocompati-
bility complex (MHC) class II+ targets that are rare. Yet CD4+
T cells are the predominant T cell subset that limits phagosomal
pathogens (Lo et al., 1999; Hess et al., 1996; Flynn et al., 1992).
However, phagosomal pathogens are slowly controlled, and are
never completely eliminated (Monack et al., 2004; Scanga et al.,
2000). On the other hand, CD8+ T cells recognize antigens on
MHC class I+ cells (almost every cell), yet they appear to play
only a secondary role against phagosomal pathogens. Phagoso-
mal pathogens present a dilemma because they are considered
highly immunosuppressive (VanHeyningen et al., 1997; Tobar
et al., 2006; Halici et al., 2008; van der Velden et al., 2005; Jo-
hanns et al., 2010), yet they induce potent CD4+ and CD8+
T cell responses (Dudani et al., 2002; Luu et al., 2006; Serbina
et al., 2000; Hone et al., 1992).
In this study, we addressed whether the location of antigen
within an infected cell influences bacterial persistence. We
used recombinants of ST that reside in the phagosomes but
display differential antigenic trafficking (cytosol versus phago-
some). Our results indicate that ST persists despite the genera-
tion of a potent CD8+ T cell response due to poor recognition of
infected cells by CD8+ T cells.
RESULTS
Antigen Translocation Does Not Affect Bacterial
Replication or Their Ability to Infect Cells
We have previously reported that infection of mice with recombi-
nant ST, expressing ovalbumin (OVA), does not induce a detect-
able CD8+ T cell response within the first week of infection (Luu
et al., 2006; Albaghdadi et al., 2009), and this is due to delayedhors
Figure 1. Antigenic Translocation Does
Not Influence Proliferation or Phagocytosis
of ST
(A and B) Truncated OVA was incorporated into
a plasmid coding for the translocation domains of
YopE. The translocation of the resulting chimeric
protein YopE-OVA to the cytosol by the type III
secretion system of ST is mediated by the YopE-
specific chaperone SycE also contained in the
plasmid.
(C) Expression of OVA, using flagellin as a loading
control, was measured in the bacterial pellet
by western blotting. Samples were normalized to
1 3 107 cells.
(D) Expression of OVA and actin in the cytosolic
and noncytosolic fraction of infected spleens (107,
i.v. at 24 hr postinfection) was measured by
western blotting.
(E) Liquid cultures of bacteria were set up in flasks,
and the bacterial growth was measured by
OD600nm at various time intervals.
(F) IC-21 macrophages (H-2b) (5 3 104/well) were
infected with bacteria (10 multiplicity of infection
[MOI]) for 30 min. After removal of extracellular
bacteria, cells were lysed at various time intervals
and bacterial burden in the macrophages deter-
mined.
(G) Bacterial burden in HeLa cells was evaluated
as described in (F).
Results represent themeanof three tosix replicates
± SD per group and are representative of three
independent experiments. See also Figure S1.antigen presentation to CD8+ T cells (Luu et al., 2006; Albagh-
dadi et al., 2009). We generated recombinants of ST that deliver
antigen to the phagosomes or cytosol of infected cells while the
pathogen still remains confined to the phagosomes.We incorpo-
rated OVA into a plasmid coding for the translocation domains of
the carrier molecule YopE (Yersinia outer-membrane protein E)
(Ru¨ssmann et al., 2001) to generate ST-YopE-OVA. The translo-
cation of the resulting chimeric protein YopE-OVA to the cytosol
by the type III secretion system of ST is mediated by the YopE-
specific chaperone SycE also contained in the plasmid (Figures
1A and 1B). The recombinant ST that does not translocate OVA
to the cytosol (ST-OVA) was previously constructed and charac-
terized (Luu et al., 2006; Albaghdadi et al., 2009). ST-OVA and
ST-YopE-OVA had similar levels of OVA expression. Intensity
of OVA expression by densitometry was 143 for ST-YopE-
OVA, 187 for ST-OVA, 17 for ST, 163 for 2 ng OVA, and 199 for
4 ng OVA. The expression of OVA in the cytosolic fraction of
spleen cells was detectable only from ST-YopE-OVA-infected
mice (Figure 1D). There was no difference in the doubling time
of ST-YopE-OVA versus ST-OVA when grown extracellularly
in vitro (Figure 1E). The uptake and the intracellular replicationCell Reports 2, 1710–1721, Deof ST within macrophages (Figure 1F)
and epithelial cells (Figure 1G) were also
similar for ST-YopE-OVA and ST-OVA.
Lack of early T cell activation based
on expression of pan-T cell activation
markers in ST-infected mice is evident insusceptible (C57BL/6J) and resistant (129X1/SvJ) mice (Figures
S1A–S1C). These results indicate that YopE does indeed
mediate the translocation of passenger antigens to the cytosol
of infected cells, and this does not influence the uptake or intra-
cellular proliferation of ST.
Antigen Translocation to Cytosol Induces Rapid Antigen
Presentation
We then ascertained the kinetics of antigen presentation by eval-
uating the expression of MHC I-OVA-peptide complex after
infection of dendritic cells with ST-OVA or ST-YopE-OVA. Infec-
tion with ST-YopE-OVA, but not ST-OVA, resulted in increased
induction of MHC I-peptide complex (Figure 2A). Furthermore,
infection of cells with ST-OVA did not result in any detectable
proliferation ofOT-1 cells, indicating lack of rapid antigenpresen-
tation to CD8+ T cells (Figure 2B). In contrast, infection with ST-
YopE-OVA resulted in proliferation of OT-1 cells, indicative of
rapid antigenpresentation in vitro (Figure 2B). As expected, infec-
tion with LM-OVA, which replicates in the cytosol of infected
cells, induced potent proliferation of OT-1 cells. Both ST-OVA
and ST-YopE-OVA induced similar antigen presentation tocember 27, 2012 ª2012 The Authors 1711
Figure 2. ST-YopE-OVA Induces Rapid Antigen Presentation
(A) Dendritic cells (JAWS) were infected with 50 MOI bacteria for 2 hr, followed by washing and culture in media containing 5 mg/ml gentamicin. At 6 hr, cells were
retrieved and the expression of MHC I-peptide complex evaluated by flow cytometry after staining with isotype or 25D1.16 antibody.
(B) IC-21 macrophages (H-2b) (105/well) were infected with bacteria for 30 min. Extracellular bacteria were removed and cells were incubated with CFSE-labeled
OT-1 TCR transgenic cells (106/well). After 3 days of culture, cells were harvested, stained with anti-CD8 antibody, and the reduction in CFSE intensity of OT-1
CD8+ T cells was evaluated by flow cytometry.
(C and D) B6.129F1 mice were infected (103, i.v.) with bacteria. At various time intervals, CFSE-labeled OT-1 cells were injected (53 106, i.v.). Four days after the
transfer of OT-1 cells, spleens were isolated from recipient mice and spleen cells were stained with OVA-tetramer and anti-CD8 antibody. Reduction of CFSE
expression was evaluated in OT-1 cells. Results represent the mean of three mice ± SD per group, and are representative of two or three independent exper-
iments (**p < 0.01).
(E) B6.129F1 mice were infected as in (C). At day 3, DCs were isolated using CD11c magnetic beads and cultured (105/well) with CFSE-labeled OT-1 cells
(105/well) for 72 hr in vitro. Reduction in CFSE expression was evaluated by flow cytometry after staining cells with anti-CD8 antibody and OVA tetramers.
(F and G) IC-21 macrophages (53 105/well) were cultured for 1 hr with lactacystin (80 mM) at 37C. Cells were infected with ST-YopE-OVA (10MOI). After 30 min,
cells were washed and kept in medium containing gentamicin (10 mg/ml) with or without lactacystin (40 mM) at 37C. After overnight incubation, cells were fixed in
0.5% paraformaldehyde followed by incubation with polylysine (2.5 mg/ml) to neutralize residual paraformaldehyde. Purified CD8+ T cells from OT-1 mice were
labeled with CFSE and added to the cultures (23 105/well). After 2 days of culture, cells were harvested, stained with anti-CD8 antibody, and reduction in CFSE
intensity of CD8+ T cells was evaluated. Results represent the mean ± SD per group, and are representative of two independent experiments (**p < 0.01).
See also Figure S2.CD4+ T cells in vitro (Figure S2). We then evaluated whether
antigen translocation induces rapid antigen presentation in vivo.
At day 4 postinfection, the majority of OT-1 cells proliferated in
mice that had been infected with ST-YopE-OVA, indicating rapid
antigen presentation (Figure 2C). In contrast, OT-1 cells prolifer-
ated poorly in ST-OVA-infected mice. We observed that OT-1
cells underwent activation in ST-OVA-infected mice only at day
11 postinfection (Figure 2 D), confirming delayed antigen presen-1712 Cell Reports 2, 1710–1721, December 27, 2012 ª2012 The Auttation. Furthermore, the magnitude of peak antigen presentation
by ST-YopE-OVA was substantially higher. Antigen presentation
that was induced early on in ST-YopE-OVA-infected mice was
reduced to baseline levels at 3 weeks postinfection, implying
lack of antigen persistence, a situation that is similar to LM
infection (van Faassen et al., 2004). Additionally, dendritic cells
isolated fromST-YopE-OVA-infectedmice at day 3 postinfection
inducedstronger proliferation of carboxyfluorescein succinimidylhors
ester (CFSE)-labeledOT-1 cells in vitro in comparison to dendritic
cells isolated from ST-OVA-infected mice (Figure 2E). These
results indicate that lack of early antigen presentation during
ST-OVA infection is related to poor antigen processing rather
than the development of suppressive dendritic cells.
Cytosolic Antigen Processing Induced by ST-YopE-OVA
Various mechanisms of antigen processing involving cytosolic
and noncytosolic (or vacuolar) pathways have been described
for the MHC class I pathway (Amigorena and Savina, 2010;
Shen and Rock, 2006). Proteasomal degradation of proteins
plays a key role in classical cytosolic antigen processing and is
specifically inhibited by lactacystin (Craiu et al., 1997). We there-
fore evaluated antigen presentation with ST-YopE-OVA-infected
antigen-presenting cells (APCs) in the presence or absence of
lactacystin. While ST-YopE-OVA-infected APCs induced anti-
gen presentation to CFSE-labeled OT-1 CD8+ T cells, lactacystin
treatment resulted in complete inhibition of this response (Fig-
ures 2F and 2G). As expected, lactacystin treatment had no
effect on the proliferation of OT-1 cells induced by OVA257-264
peptide that is directly loaded ontoMHC I. These results indicate
that antigen presentation against ST-YopE-OVA was induced by
the classical cytosolic antigen-processing pathway, and a lack
of cytosolic antigen processing in ST-OVA-infected cells leads
to poor CD8+ T cell activation initially.
Cytosolic Antigen Presentation Results in Pathogen
Control and Induction of Early CD8+ T Cell Response
We infected B6.129F1-resistant mice with ST-OVA and ST-
YopE-OVA. At day 3 postinfection, mice infected with ST-
YopE-OVA or ST-OVA had similar bacterial burdens (Figure 3A).
Subsequently, the burden of ST-YopE-OVA was controlled and
reduced to nondetectable levels by day 15. In contrast, ST-
OVA burden was maintained at high levels, as expected, for pro-
longed periods (Figure 3A). Similar results were noted in the liver
(data not shown). Furthermore, mice infected with ST-YopE-
OVA had lower spleen size (Figure 3B). Infection of mice with
ST-YopE-OVA resulted in the development of a rapid and potent
endogenous OVA-specific CD8+ T cell response, which peaked
at day 7 (Figures 3C and S3A). As expected, infection of mice
with ST-OVA resulted in a delayed CD8+ T cell response that
was nondetectable at day 7 and peaked around day 20. At day
21 postinfection, ST-OVA-infected mice had high numbers of
OVA-specific CD8+ T cells (Figure 3C), but this did not result in
rapid clearance of ST-OVA subsequently (Figure 3A).
We observed that infection with ST-YopE-OVA, but not ST-
OVA, resulted in rapid downregulation of CD62L—as early as
day 5—and rapid progression to the memory state (Figures
3D–3F and S3B). Thus, early cytosolic antigen processing and
presentation, in the context of ST, accelerates the kinetics and
increases CD8+ T cell differentiation and memory development.
We also measured the frequency of OVA-specific CD8+ T cells
by ELISPOT assay ex vivo. Again, ST-YopE-OVA-infected mice
displayed a rapid generation of OVA-specific, interferon g (IFN-
g)-secreting CD8+ T cells (Figure 3G). This was followed by
a rapid contraction of the response and maintenance of a stable
pool of IFN-g-secreting, OVA-specific CD8+ T cells. Mice in-
fected with ST-OVA, on the other hand, displayed a delayedCell Reresponse that increased progressively and even surpassed the
response observed in ST-YopE-OVA-infected mice (Figure 3G).
We also measured cytolytic activity of OVA-specific CD8+ T cells
in vivo. ST-YopE-OVA-infected mice generated a rapid and
potent cytolytic response (Figure 3H) that declined progres-
sively, commensurate with reduction in the frequency of OVA-
specific CD8+ T cells. On the other hand, mice infected with
ST-OVA generated minimal cytolytic response early on, which
increased progressively to high levels by day 30 postinfection
(Figure 3H).
We addressed whether the delivery of other antigens through
the type III secretion system of ST would also evoke efficient
control of infection. Therefore, similar to ST-OVA and ST-
YopE-OVA, recombinants of ST were generated to express an
immunodominant epitope-containing fragment of the LCMV
nucleoprotein (NP) that fused to YopE (ST-YopE-NP) or not
(ST-NP). Both the ST-NP and ST-YopE-NP constructs ex-
pressed similar levels of NP (data not shown). A similar bacterial
burden was noted in the spleens of mice infected with ST-NP
and ST-YopE-NP at day 1 and 3 postinfection (Figure 3 I). At later
time intervals, while the ST-NP burden remained at high levels,
the burden of ST-YopE-NP was controlled. The kinetics of
CD8+ T cell response was rapid for ST-YopE-NP and delayed
(as expected) for ST-NP (Figure 3J). Furthermore, ST-NP-in-
fected mice displayed a massive increase in the number of
spleen cells (Figure 3K). Thus, these results indicate that the
phenomenon described herein is observed with other antigens.
Control of Pathogen Burden and Development of Rapid
CD8+ T Cell Response in Susceptible Mice
C57BL/6J mice are highly susceptible to ST and die within the
first week of infection (Albaghdadi et al., 2009). At day 1 and
day 3 postinfection, similar bacterial burdens were noted in
ST-OVA- infected and ST-YopE-OVA-infected C57BL/6J mice
(Figure 4A). Subsequently, the bacterial burden in ST-OVA-in-
fected mice continued to increase exponentially to lethal levels
(>108), whereas the burden in ST-YopE-OVA-infected mice
was rapidly controlled (<103) and became undetectable at day
14. Abridgment of chronicity in ST-YopE-OVA-infected mice
correlated to the early emergence of potent OVA-specific
CD8+ T cell response (Figure 4B). We evaluated the long-term
survival of ST-YopE-OVA- infected versus ST-OVA-infected
C57BL/6J mice. Whereas all of the ST-OVA-infected mice died
within the first week of infection, ST-YopE-OVA-infected mice
displayed a significant increase in survival, with >50% surviving
beyond day 90 postinfection (Figure 4C). Similar results were ob-
tained with ST-YopE-NP (Figure 4D). We measured the colony-
forming units (cfu) in the spleens of moribund ST-YopE-OVA-in-
fected mice between days 20 and 30 postinfection, and noted
that the bacteria in these mice had lost the plasmid as revealed
by total absence of cfu in Ampicillin plates (Figure 4E). These
results indicate that potent CD8+ T cell response selects for
antigenic loss variants in susceptible hosts. We evaluated the
survival of Rag-1-deficient C57BL/6J mice infected with ST-
OVA or ST-YopE-OVA. Both ST-OVA-infected and ST-YopE-
OVA-infected mice were moribund between days 10 and 15
postinfection (Figure 4F), suggesting that YopE expression by
ST does not attenuate the bacterium. Infection with a 100-foldports 2, 1710–1721, December 27, 2012 ª2012 The Authors 1713
Figure 3. Antigen Translocation Leads to Rapid Control of ST
(A–H) B6.129F1 mice were infected (103, i.v.) with bacteria. At various time intervals, spleen cells were removed and bacterial burden evaluated (A). Difference in
spleen size in ST-OVA-infected versus ST-YopE-OVA-infectedmice (B). Spleen cells were stained with OVA-tetramer and anti-CD8 antibody, and the numbers of
OVA-specific CD8+ T cells evaluated (C). Cells were also stained with antibodies against CD62L and CD127 (D). The expression (mean fluorescence intensity) of
CD62L (D and E) and CD127 (D and F) on OVA-tetramer+CD8+ T cells was evaluated. Frequency of OVA-specific CD8+ T cells per spleen was also evaluated by
ELISPOT assay at various time intervals postinfection (G). In the absence of peptide stimulation, the number of spots was less than 500 per spleen. In vivo cytolytic
activity of OVA-specific CD8+ T cells was evaluated by injecting CFSE-labeled, OVA-pulsed, and control spleen cells from naive B6.129F1mice into naive or
infected mice. Fate of injected targets was evaluated 24 hr later (H).
(I–K) B6.129F1mice were infected (103, i.v.) with ST-NP and ST-YopE-NP. At various time intervals, spleens were removed from infectedmice. Bacterial burdens
were evaluated by plating serial dilutions on BHI-agar plates (I). Frequency of NP-specific CD8+ T cells was evaluated by ELISPOT assay (J). The number of spleen
cells was evaluated at various time intervals in the two groups of mice (K).
Results represent the mean of three to five mice ± SD per group (C, E–K) and are representative of three independent experiments (**p < 0.01 and *p < 0.05). See
also Figure S3.higher dose of ST-OVA in comparison to ST-YopE-OVA did
not influence the kinetics of CD8+ T cell response or ST-OVA
control (Figures S4A and S4B). Taken together, these results
underscore the importance of this paradigm wherein the deposi-
tion of antigen into the appropriate intracellular compartment
can modulate host survival profoundly.
CD8+ T Cells Control ST-YopE-OVA
We next evaluated whether the control of ST-YopE-OVA was
indeed mediated by CD8+ T cells. B6.129F1 mice were depleted
of CD4+ or CD8+ T cells and infected with ST-YopE-OVA. At day
7 postinfection, mice depleted of CD8+ T cells, but not CD4+1714 Cell Reports 2, 1710–1721, December 27, 2012 ª2012 The AutT cells, had >100-fold higher ST-YopE-OVA burden than
controls, demonstrating that CD8+ T cells controlled ST-YopE-
OVA (Figure 5A). Interestingly, after depletion of CD8+ T cells,
the bacterial burden in the spleens of ST-YopE-OVA-infected
mice at day 7 was 105, which was similar to the burden noted
in mice infected with ST-OVA (Figure 3A). In mice infected with
ST-OVA, depletion of CD4+ or CD8+ T cells had no effect on
the bacterial burden (Figure 5B).We further confirmed the impor-
tance of CD8+ T cells in controlling ST-YopE-OVA burden by in-
fecting wild-type,MHC I-deficient, or MHC II-deficient C57BL/6J
mice with ST-YopE-OVA. MHC class I-deficient mice were mori-
bund and harbored very high bacterial loads (108) (Figure 5C),hors
Figure 4. ST-YopE-OVA Infection Results in
Rapid CD8+ T Cell Response and Pathogen
Control in Susceptible Mice
(A–C) C57BL/6J mice were infected (103, i.v.) with
bacteria. At various time intervals spleens were
removed and the bacterial burdens enumerated.
Spleen cells were stained with OVA-tetramer and
anti-CD8 antibody and the numbers of OVA-
tetramer+ CD8+ T cells per spleen at various time
intervals enumerated. Survival was assessed by
monitoring the weights and clinical signs of mice.
(D) C57BL/6Jmicewere infected (103, i.v.) with ST-
NP or ST-YopE-NP. Survival was assessed by
monitoring the weights and clinical signs of mice.
(E) C57BL/6Jmice were infected (103, i.v.) with ST-
YopE-OVA. Between days 20 and 30, the spleens
of moribund mice were removed and bacterial
burden evaluated on ampicillin-coated or control
BHI-agar plates.
(F) B6.Rag1-deficient mice were infected (103, i.v.)
with bacteria, and survival of mice was monitored.
Results represent the mean ± SD per group
(B, E) and are representative of two independent
experiments (**p < 0.01).
See also Figure S4.whereas MHC class II-deficient mice had very low bacterial
burden that was not statistically different from control wild-
type hosts. Further experiments indicated that even if the CD8+
T cell response is forcibly delayed, complete elimination of
ST-YopE-OVA by CD8+ T cells still occurs in resistant mice, indi-
cating that the timing of CD8+ T cell activation (early or delayed)
does not influence the control of ST-YopE (Figure S5). Thus,
these results indicate that deposition of antigen into the cytosol
of infected cells induces CD8+ T cell-dependent control of an
otherwise uncontrollable infection.
Target Cell Recognition by CD8+ T Cells Is a Critical
Factor in Control of ST-YopE
We addressed whether target cell recognition by CD8+ T cells is
the main reason that facilitates efficient control of ST-YopE-
OVA. We generated activated OVA-specific CD8+ T cells by
stimulating OT-1 cells in vitro with LM-OVA. These primed
CD8+ T cells were then tested for their ability to specifically kill
infected macrophages (Figure 6A). Activated OVA-specific
CD8+ T cells killed macrophages only when they were infected
with ST-YopE-OVA, but not ST-OVA or ST (Figure 6B). We
also generated OVA-specific memory CD8+ T cells in C57BL/
6J mice after infecting them with LM-OVA. At day 41, mice
were challenged with ST-OVA or ST-YopE-OVA (Figure 6C).
Challenge of immunized mice with ST-YopE-OVA resulted in
expansion of OVA-specific CD8+ T cells in the blood (data not
shown) and spleen at day 3 (Figure 6E) and day 5 (Figures 6D
and 6E) postchallenge. In contrast, challenge with ST-OVA
failed to induce the expansion of OVA-specific memory CD8+
T cell response. Bacterial burden in the spleen of immunized
mice challenged with ST-YopE-OVA was undetectable (Fig-
ure 6F). In contrast, priming with LM-OVA had no significant
effect on the burden of ST-OVA (Figure 6F). Thus, these results
indicate that ST-OVA infection of host cells results in a lack ofCell Retarget cell recognition by primed CD8+ T cells, which leads to
pathogen chronicity.
Bacterial Chronicity Promotes Inflammation and
Immune-Evasive Mechanisms
Because chronic intracellular bacteria are associated with
numerous immune-evasive mechanisms, we were interested
in determining whether these mechanisms are modulated by
YopE-mediated antigenic delivery into the cytosol of infected
cells. We evaluated cytokine/chemokine expression in the serum
of infected mice using a cytokine array. At day 4 postinfection,
there was similar induction of cytokines/chemokines in mice in-
fected with ST-OVA and ST-YopE-OVA (Figures 7A and 7B),
commensurate with similar bacterial burden in the spleen (Fig-
ure 7C). Interestingly, at day 14, when the bacterial burden
was controlled in ST-YopE-OVA-infected mice, the expression
of cytokines/chemokines was reduced to baseline levels in ST-
YopE-OVA-infected mice in comparison to ST-OVA-infected
mice (Figure 7B). The expression of both inflammatory and
anti-inflammatory cytokines was exacerbated by bacterial chro-
nicity. These results indicate that pathogen chronicity is not due
to a selective induction of anti-inflammatory mechanisms.
We also evaluated the induction of CD4+CD25+FoxP3+
(T regulatory cells [T-regs]) in mice infected with ST-OVA versus
ST-YopE-OVA. During the initial stages of infection, there was
a similar increase in the numbers of T-regs in the two groups
of mice (Figure S6A). Subsequently, the numbers of T-regs
continued to increase in ST-OVA-infected mice, whereas the
numbers of T-regs decreased precipitously at day 14 in ST-
YopE-OVA-infected mice (Figure S6B). Depletion of T-regs in
ST-OVA-infected mice did not alter the numbers of OVA-specific
CD8+ T cells significantly (Figures S6C and S6D). Thus, these
results indicate that immune-suppressive mechanisms are not
the reason for delayed kinetics of CD8+ T cell priming against ST.ports 2, 1710–1721, December 27, 2012 ª2012 The Authors 1715
Figure 5. CD8+ T Cells Control ST-YopE-OVA Burden in Suscep-
tible Mice
C57BL/6Jmice were injected intraperitoneally with (100 mg/injection) anti-CD4
(cloneGK1.5), anti-CD8 (clone 2.43), or Rat IgG isotype antibodies on days3,
0, and 3 after infection with 103 ST-YopE-OVA or 103 ST-OVA. At day 7
postinfection, spleens were harvested and the bacterial burden evaluated
(A, B). Results represent the mean of three to four mice ± SD per group. Wild-
type, MHC I-deficient, or MHC II-deficient mice (all on B6 background) were
infected with 103 ST-YopE-OVA (C). At day 20 postinfection, spleens were
harvested and the bacterial burden evaluated (C). Results represent the mean
of five mice ± SD per group (**p < 0.01). Results are representative of two
independent experiments.DISCUSSION
Intracellular bacteria that reside in the phagosomes of infected
cells, such as ST and Mycobacterium tuberculosis, present a
dilemma, because they are considered immune evasive yet
highly immunogenic at the same time (Jones and Falkow,
1996; Flynn and Chan, 2001). They induce potent CD4+ and
CD8+ T cell responses (Srinivasan et al., 2004a; Serbina and1716 Cell Reports 2, 1710–1721, December 27, 2012 ª2012 The AutFlynn, 2001; Stover et al., 1991; Dudani et al., 2002), but the
pathogens are never completely eliminated (Monack et al.,
2004; Scanga et al., 2000). It is thus not clear how these patho-
gens persist despite the generation of potent T cell responses.
We addressed the possibility that poor recognition of infected
cells, specifically by CD8+ T cells, may be the key mechanism
of immune evasion.
Although CD8+ T cells efficiently eliminate LCMV and LM (Ka¨gi
et al., 1994; Harty and Bevan, 1992), they appear to play only
a secondary role in controlling ST (Lo et al., 1999; Hess et al.,
1996) despite induction of a potent CD8+ T cell response in the
long-term (Luu et al., 2006). CD4+ T cells appear to be the
predominant immune cell that limits ST in resistant mice (Lo
et al., 1999; Dougan et al., 2011). However, ST is never com-
pletely eliminated (Monack et al., 2004), because it takes
>90 days to bring the bacterial burden to undetectable levels
in resistant mice (Luu et al., 2006). Our results indicate that
whenCD8+ T cells aremade to recognize infected cells appropri-
ately, they become the most important and protective cell type
that profoundly modulates the duration of infection. These
results imply that CD8+ T cellsmay bemore efficient atmediating
immune surveillance than CD4+ T cells. A possible explanation
for this may be related to the ubiquitous expression of MHC I
on all cells in comparison to the selective expression of MHC II
only on some cells.
Cross-presentation of noncytosolic antigens has been re-
vealed as an alternate pathway that results in the induction of
CD8+ T cell response (den Haan and Bevan, 2001; Wei et al.,
2010; Hirosue et al., 2010; Basta et al., 2002; Goldszmid et al.,
2009). Because ST-OVA/NP resides predominantly in the phag-
osome of infected cells, it is likely that CD8+ T cells are activated
mainly through cross-presentation. Various antigen-processing
pathways can be considered against ST-OVA/NP, such as phag-
osomal-cytosolic pathway, endoplasmic reticulum-phagosome
fusion, vacuolar pathway, endosome-to-endoplasmic reticulum
pathway and endoplasmic reticulum-associated degradation
pathway (Houde et al., 2003; Shen and Rock, 2006; Yrlid and
Wick, 2000; Winau et al., 2006). Alternatively, it is possible that
some amount of antigen leaks to the cytosol even during infec-
tion with ST-OVA, and this process may be inefficient and pro-
tracted. Further studies are therefore required to determine the
contribution of these pathways during infection with ST-OVA.
On the other hand, antigens localized in the cytosol of host cells
are processed through the cytosolic pathway, which is depen-
dent on proteasomal degradation (Goldberg et al., 2002). Our
results indicate that this seems to be the main pathway that
operates when antigen expressed by ST is translocated to the
cytosol.
CD8+ T cells can efficiently control a pathogen only when the
target cells that harbor the pathogen also display pathogen-
derived peptide on the cell surface. It is likely that this does not
happen in the case of phagosomal pathogens. Although cross-
presentation of antigen after death of infected targets can acti-
vate CD8+ T cells by the alternative pathway (Albert et al.,
1998; Yrlid and Wick, 2000), this mechanism may not promote
recognition of ‘‘infected’’ target cells by primed CD8+ T cells.
Thus, target cells that contain the pathogen but fail to display
pathogen-derived peptides on the cell surface will be sparedhors
Figure 6. Target Cell Recognition by CD8+ T Cells Leads to Control of ST-YopE-OVA
(A and B) OT-1 spleen cells (108) were infected with LM-OVA (103) followed by washing and culture in media containing gentamicin at 18 hr. Activated OT-1 CD8+
T cells were subsequently cultured in media containing interleukin 7 (1 ng/ml) for 7 days. These cells (>99% CD8+) were added (1:1) on top of adherent IC-21
macrophages that were previously infected (for 2 hr) with various bacteria as indicated (A). After overnight culture, OT-1 cells were removed by washing and the
survival of adherent IC-21 macrophages evaluated by staining with neutral red followed by colorimetric measurement. Results represent the mean ± SD per
group.
(C–F) C57BL/6Jmice were injected with 104 OT-1 (45.1+) cells and infected with 104 LM-OVA (C). At 41 days postinfection, groups of mice were rechallengedwith
PBS or 103 ST-YopE-OVA or ST-OVA. Control groups of mice that were not primed with LM-OVA were challenged with the same dose of ST-OVA or ST-YopE-
OVA. At days 0, 3, and 5 postrechallenge, spleens were isolated and spleen cells stained with OVA-tetramers and antibodies against CD8 and CD45.1. The
relative numbers of CD45.1+OT-1 cells in the spleen were enumerated (D and E), and bacterial burden in the spleen evaluated (F). Results represent the mean of
three mice ± SD per group (E, F) (**p < 0.01; ns, nonsignificant).
See also Figure S5.from a CD8+ T cell attack, which will lead to immune evasion and
chronicity. ST induces CD8+ T cell activation, albeit delayed,
suggesting that native ST antigens contain CD8+ T cell epitopes,
although their identity is unknown. It is unclear whether such
CD8+ T cell epitopes are present in the virulence proteins of ST
that are secreted through the type III secretion system.
Phagosomal pathogens have been shown to engage immuno-
suppressivemechanisms (Kaufmann, 1993; VanHeyningen et al.,
1997; van der Velden et al., 2005;Geijtenbeek et al., 2003;Chem-
inay et al., 2005; Qimron et al., 2004; Johanns et al., 2010), which
have been considered to favor immune evasion and pathogen
chronicity. ST inhibits antigen presentation (Tobar et al., 2006;
Halici et al., 2008; van der Velden et al., 2005; Cheminay et al.,
2005; Qimron et al., 2004). ST has also been shown to inhibitCell ReCD8+ T cell activation through a direct, contact-dependent
mechanism (van der Velden et al., 2005). However, other reports
have failed to reveal any inhibition of antigen presentation by ST
(Niedergang et al., 2000; Petrovska et al., 2004; Wijburg et al.,
2002; Albaghdadi et al., 2009) as potent T cell responses are
induced by these pathogens in the long-term (Dudani et al.,
2002; Luu et al., 2006; Serbina et al., 2000; Hone et al., 1992).
Indeed, the CD8+ T cell response induced against salmonella
and mycobacteria is highly potent in magnitude (Stover et al.,
1991; Pasetti et al., 2011). Our results suggest that the suppres-
sion of host immunity during ST infection is a consequence of the
persistence of the pathogen and not the reason of chronicity.
When LM was relocated from cytosol to phagosomes, due to
disruption of the lisA gene coding for Listeriolysin, this resulted inports 2, 1710–1721, December 27, 2012 ª2012 The Authors 1717
Figure 7. Pathogen Chronicity Exacerbates Cytokine Expression
(A–C) B6.129F1 mice were infected (103, i.v.) with bacteria. At days 4 and 14 postinfection, serum was isolated from infected mice and the expression of
cytokines/chemokines evaluated bymouse cytokine array as described in Experimental Procedures (A). Fold change in cytokine/chemokine levels in comparison
to naive mice was evaluated (B). Bacterial burden in the infected mice was evaluated in the spleens (C). Results represent the mean of three mice ± SD per group
and were performed twice.
See also Figure S6.a poor CD8+ T cell response due to the induction of interleukin
10 expression and poor maturation of DCs (Bahjat et al., 2009).
This has led to the notion that phagosomal residence is immuno-
suppressive. In the case of LM, the entire organism was relo-
cated from cytosol to the phagosomes, where the pathogen
would be forced to interact with different sets of signaling mole-
cules (Bahjat et al., 2009). Because LM has not evolved to reside
in phagosomes, this may explain why relocation of LM caused
attenuation of virulence, and induction of suppression (Bahjat
et al., 2009). In our model, only the antigen expressed by ST
was relocated to the cytosol. Thus, the innate immune sensors
engaged by ST in the phagosomal compartment would be the
same whether the antigen was in the cytosol or the phagosome.
Furthermore, our results clearly indicate that the expression of
immunosuppressive mechanisms, such as the induction of
T-regs, gets exacerbated with pathogen-persistence, suggest-
ing that chronicity leads to immunosuppression.
Considering the numerous genes that pathogens such as ST
employ for virulence and chronicity (Jones and Falkow, 1996),
our results provide insights into the power of the acquired1718 Cell Reports 2, 1710–1721, December 27, 2012 ª2012 The Autimmune system, wherein engagement of the cytosolic antigen
presentation can be sufficient to control an otherwise uncontrol-
lable bacterium. Although our model involves translocating OVA
and NP, not ST-derived antigens, into the cytosol of ST-infected
cells, it provides an important proof of concept demonstrating
the power of CD8+ T cells to abridge pathogen chronicity with
a singlemodification of antigenic translocation. Efforts in vaccine
development against phagosomal pathogens are often geared
toward inducing CD8+ T cell response. However, our results
suggest that strategies for controlling phagosomal pathogens
have to include ways of modulating antigen presentation such
that infected target cells can be readily recognized by CD8+
T cells.EXPERIMENTAL PROCEDURES
Mice and Infections
C57BL/6J, B6.OT-2, 129x1/SvJ, B6.129S2-H2dlAb1-Ea/J, B6.129S7-
Rag1tm1Mom/J, B6.129P2-B2mtm1Unc/J, and OT-I TCR-transgenic mice were
obtained from The Jackson Laboratory. CD45.1+ OT-1 TCR transgenic micehors
were generated in-house. B6129F1micewere generated bymating 129x1/SvJ
females with C57BL/6Jmales.Miceweremaintained at the Institute for Biolog-
ical Sciences, Ottawa, Canada, in accordance with Canadian Council on
Animal Care guidelines. For infection, mice were injected intravenously (i.v.)
with 103 organisms suspended in 200 ml NaCl (0.9%) via the lateral tail vein.
Recombinant Bacteria
Recombinant ST (strain SL1344) that does not translocate antigen (OVA) to the
cytosol has been published previously as ST-OVA (Luu et al., 2006). Recombi-
nant ST that translocates OVA to the cytosol (ST-YopE-OVA) was generated
by transformation of ST (strain SL1344) with the plasmid pHR-OVA by electro-
poration. This plasmid was generated through the modification of plasmid
pHR-241 (Ru¨ssmann et al., 2001), which contains the sequence for the
YopE-specific chaperone SycE and the fusion protein YopE-p60/M45. Briefly,
the sequences for p60/M45 were replaced by the OVA sequence coding for
amino acids 134 to 386 with BamHI and KpnI restriction sites added to use
for inserting the plasmid. The following primers were used for this: 50-CG
GGATCCAACTTTCAAACAGCTG-30; GGGGTACCTTAAGGGGAAACACATC-
30. We also cloned the LCMV NP encoded by amino acids 396–404
(FQPQNGQFI) into ST. cDNA encoding amino acids 288–508 of the NP protein
(GenBank accession number NP_694852.1) was cloned into the plasmid, pHR,
to generate ST-YopE-NP. The cDNA insert for this was amplified from a pre-
existing full-length clone for NP using oligonucleotides with BamHI and KpnI
restriction sites added to use for inserting into the plasmid. The oligonucleotide
sequences used for the cDNA amplification were: 50 CTGGATCCTTTGTTTCA
GACCAAGT 30 and 50 TAGGTACCCTAGTCCCTTACTATTCC 30. cDNA encod-
ing amino acids 288–463 of the NP protein was similarly cloned into the
plasmid, pKK, to generate ST-NP. In this case, NcoI andHindIII restriction sites
were added to the oligonucleotides used for amplification of the insert
sequence. The oligonucleotide sequences used for the cDNA amplification
were: 50 TACCATGGCATTTGTTTCAGACCAAGT 30 and 50 TAAAGCTTCTAG
TCCCTTACTATTCCAG 30. After confirmation of the sequences, these plas-
mids were electroporated into the SL1344 ST strain.
Western Blotting
Bacteria grown in liquid culture were tested for OVA and flagellin expression.
Spleens were obtained from C57BL/6J mice infected with 107 bacteria after
1 day of infection. Cytosolic and noncytosolic proteins were isolated following
cell lysing in isotonic buffer and differential centrifugation (Ru¨ssmann et al.,
2001; Timmons et al., 2011). Samples were normalized for cell number and
were loaded on SDS-10% polyacrylamide gels and OVA and actin expression
measured by enhanced chemiluminescence.
Flow Cytometry
Aliquots of spleen cells (5 3 106) were incubated in 80 ml PBS plus 1% BSA
(PBS-BSA) with anti-CD16/32 at 4C. After 10 min, cells were stained with
H-2KbOVA257–264 tetramer-PE (Beckman Coulter) and various antibodies
(anti-CD8 PercP-Cy5, anti-CD62L APC-Cy7, anti-CD127 PE-Cy7, and anti-
CD45.1 APC) for 30 min. Cells were washed with PBS, fixed with 1% formal-
dehyde, and acquired on BD Biosciences Flow Cytometer. All antibodies
were obtained from BD Biosciences. T-regs were enumerated using Mouse
T-regulatory T cell Staining kit (e-Bioscience Cat#88-8115). Intracellular stain-
ing was done according to the manufacturer’s protocol.
Infection of Cells and Antigen Presentation
Antigen presentation was done as described previously (van Faassen et al.,
2004; Albaghdadi et al., 2009). For in vitro antigen presentation, IC-21 macro-
phages (H-2b) were pulsed with the bacteria, followed by removal of extracel-
lular bacteria with gentamicin and incubation with CFSE-labeled OT-1 cells for
3 days. For in vivo antigen presentation, mice were infected with bacteria, fol-
lowed by adoptive transfer of CFSE-labeled OT-1 cells at various time inter-
vals. Four days after the OT-1 transfer, spleens were removed from recipient
mice and the reduction in CFSE expression on donor OT-1 cells was evaluated.
ELISPOT and In Vivo Cytolytic Activity
Enumeration of IFN-g-secreting cells was done by ELISPOT assay as previ-
ously described (Dudani et al., 2002). In vivo cytolytic activity of antigen-Cell Respecific CD8+ T cells was enumerated as previously described (Tzelepis
et al., 2008).
Cytokine Array
Serum was collected for proteomic analysis using the Mouse Proteome Array
kit (R&D Systems). Expression of cytokines/chemokines was quantitated by
chemiluminescence detected using a Fluorochem 8900 imager (Alpha Inno-
tech). Densitometric expression values were enumerated using AlphaEase
software and were corrected to the internal positive controls and expressed
as mean fold change over uninfected samples.
Statistical Analysis
The values of samples were compared by one-way ANOVA followed by Tukey
HSD tests available at the site http://faculty.vassar.edu/lowry/VassarStats.
html. The differences were considered significant when the p value was <0.05.
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